Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 49
Filter
1.
Breast Cancer Res Treat ; 203(2): 291-306, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37851288

ABSTRACT

PURPOSE: Breast cancer is a molecularly heterogeneous disease, and multiple genetic variants contribute to its development and prognosis. Most of previous genome-wide association studies (GWASs) and polygenic risk scores (PRSs) analyses focused on studying breast cancers of Caucasian populations, which may not be applicable to other population. Therefore, we conducted the largest breast cancer cohort of Taiwanese population to fill in the knowledge gap. METHODS: A total of 152,534 Participants recruited by China Medical University Hospital between 2003 and 2019 were filtered by several patient selection criteria and GWAS quality control steps, resulting in the inclusion of 2496 cases and 9984 controls for this study. We then conducted GWAS for all breast cancers and PRS analyses for all breast cancers and the four breast cancer subtypes, including luminal A, luminal B, basal-like, and HER2-enriched. RESULTS: The GWAS analyses identified 113 SNPs, 50 of which were novel. The PRS models for all breast cancers and the luminal A subtype showed positively correlated trends between the PRS and the risk of developing breast cancer. The odds ratios (95% confidence intervals) for the groups with the highest PRS in all breast cancers and the luminal A subtype were 5.33 (3.79-7.66) and 3.55 (2.13-6.14), respectively. CONCLUSION: In summary, we explored the association of genetic variants with breast cancer in the largest Taiwanese cohort and developed two PRS models that can predict the risk of developing any breast cancer and the luminal A subtype in Taiwanese women.


Subject(s)
Breast Neoplasms , Genome-Wide Association Study , Female , Humans , Breast Neoplasms/epidemiology , Breast Neoplasms/genetics , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide , Prognosis , Risk Factors , East Asian People/genetics
2.
J Clin Invest ; 134(2)2024 Jan 16.
Article in English | MEDLINE | ID: mdl-37988169

ABSTRACT

Alzheimer's disease is characterized by the accumulation of amyloid-ß plaques, aggregation of hyperphosphorylated tau (pTau), and microglia activation. Galectin-3 (Gal3) is a ß-galactoside-binding protein that has been implicated in amyloid pathology. Its role in tauopathy remains enigmatic. Here, we showed that Gal3 was upregulated in the microglia of humans and mice with tauopathy. pTau triggered the release of Gal3 from human induced pluripotent stem cell-derived microglia in both its free and extracellular vesicular-associated (EV-associated) forms. Both forms of Gal3 increased the accumulation of pathogenic tau in recipient cells. Binding of Gal3 to pTau greatly enhanced tau fibrillation. Besides Gal3, pTau was sorted into EVs for transmission. Moreover, pTau markedly enhanced the number of EVs released by iMGL in a Gal3-dependent manner, suggesting a role of Gal3 in biogenesis of EVs. Single-cell RNA-Seq analysis of the hippocampus of a mouse model of tauopathy (THY-Tau22) revealed a group of pathogenic tau-evoked, Gal3-associated microglia with altered cellular machineries implicated in neurodegeneration, including enhanced immune and inflammatory responses. Genetic removal of Gal3 in THY-Tau22 mice suppressed microglia activation, reduced the level of pTau and synaptic loss in neurons, and rescued memory impairment. Collectively, Gal3 is a potential therapeutic target for tauopathy.


Subject(s)
Galectin 3 , Tauopathies , tau Proteins , Animals , Humans , Mice , Alzheimer Disease/pathology , Disease Models, Animal , Galectin 3/genetics , Galectin 3/metabolism , Induced Pluripotent Stem Cells/metabolism , Mice, Transgenic , Microglia/pathology , tau Proteins/genetics , tau Proteins/metabolism , Tauopathies/genetics , Tauopathies/metabolism
3.
Biomedicine (Taipei) ; 13(3): 9-24, 2023.
Article in English | MEDLINE | ID: mdl-37937061

ABSTRACT

Background: Testing for prostate-specific antigen (PSA) is often recommended for men with a potential risk of prostate cancer (PCa) before requiring advanced examination. However, the best PSA cutoff value remains controversial. Object: We compared the predictive performance of age-specific percentile-based PSA thresholds with a conventional cutoff of >4 ng/mL for the risk of PCa. Methods: We included men who received PSA measurements between 2003 and 2017 in a medical center in Taiwan. Logistic regression modeling was used to assess the association between age-specific percentile-based PSA thresholds and PCa risk in age subgroups. We further applied C-statistic and decision curve analysis to compare the predictive performance of age-specific percentile-based PSA with that of a conventional cutoff PSA. Results: We identified 626 patients with PCa and 40 836 patients without PCa. The slope of PSA in patients >60-year-old was almost 3 times that of those <60-year-old (0.713 vs 0.259). The risk effect sizes of the 75th percentile PSA cutoff (<60-year-old: 2.19; 60-70-year-old: 4.36; >70-year-old: 5.84 ng/mL) were comparable to those observed based on the conventional cutoff in all age groups. However, the discrimination performance of the 75th percentile PSA cutoff was better than that of the conventional cutoff among patients aged <60-year-old (C-statistic, 0.783 vs. 0.729, p < 0.05). The 75th percentile cutoffs also correctly identified an additional 2 patients with PCa for every 100 patients with PSA screening at the threshold probability of 20%. Conclusions: Our data support the use of the 75th percentile PSA cutoff to facilitate individualized risk assessment, particularly for patients aged <60-year-old.

4.
J Invest Dermatol ; 143(11): 2120-2131.e7, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37207806

ABSTRACT

Sebaceous glands (SGs) are holocrine glands that produce sebum, which primarily contains lipids that help to maintain the barrier function of the skin. Dysregulated lipid production contributes to the progression of some diseases characterized by dry skin, including atopic dermatitis. Although the lipid production of SGs has been well-studied, few studies have assessed their role in skin immune responses. We found that SGs and sebocytes expressed IL-4 receptor and produced high levels of T helper 2-associated inflammatory mediators after IL-4 treatment, suggesting immunomodulatory effects. Galectin-12 is a lipogenic factor expressed in sebocytes that affects their differentiation and proliferation. Using galectin-12-knockdown sebocytes, we showed that galectin-12 regulated the immune response in cells exposed to IL-4 and promoted CCL26 expression by upregulating peroxisome proliferator-activated receptor-γ. Moreover, galectin-12 suppressed the expression of endoplasmic reticulum stress-response molecules, and CCL26 upregulation by IL-4 was reversed after sebocyte treatment with inducers of endoplasmic reticulum stress, suggesting that galectin-12 controls IL-4 signaling by suppressing endoplasmic reticulum stress. Using galectin-12-knockout mice, we showed that galectin-12 positively regulated the IL-4-induced enlargement of SGs and the development of an atopic dermatitis-like phenotype. Thus, galectin-12 regulates the skin immune response by promoting peroxisome proliferator-activated receptor-γ expression and suppressing endoplasmic reticulum stress in SGs.

5.
Glycoconj J ; 40(3): 295-303, 2023 06.
Article in English | MEDLINE | ID: mdl-37052731

ABSTRACT

Sialylation is an important terminal modification of glycoconjugates that mediate diverse functions in physiology and disease. In this review we focus on how altered cell surface sialylation status is sensed by cytosolic galectins when the integrity of intracellular vesicles or organelles is compromised to expose luminal glycans to the cytosolic milieu, and how this impacts galectin-mediated cellular responses. In addition, we discuss the roles of mammalian sialidases on the cell surface, in the organelle lumen and cytosol, and raise the possibility that intracellular glycan processing may be critical in controlling various galectin-mediated responses when cells encounter stress.


Subject(s)
Galectins , Polysaccharides , Animals , Galectins/metabolism , Cytosol/metabolism , Polysaccharides/metabolism , Glycoconjugates/metabolism , Organelles , Mammals/metabolism
6.
Neuroscience ; 520: 1-17, 2023 06 01.
Article in English | MEDLINE | ID: mdl-37004908

ABSTRACT

Dietary modifications often have a profound impact on the penetrance and expressivity of neurological phenotypes that are caused by genetic defects. Our previous studies in Drosophila melanogaster revealed that seizure-like phenotypes of gain-of-function voltage-gated sodium (Nav) channel mutants (paraShu, parabss1, and paraGEFS+), as well as other seizure-prone "bang-sensitive" mutants (eas and sda), were drastically suppressed by supplementation of a standard diet with milk whey. In the current study we sought to determine which components of milk whey are responsible for the diet-dependent suppression of their hyperexcitable phenotypes. Our systematic analysis reveals that supplementing the diet with a modest amount of milk lipids (0.26% w/v) mimics the effects of milk whey. We further found that a minor milk lipid component, α-linolenic acid, contributed to the diet-dependent suppression of adult paraShu phenotypes. Given that lipid supplementation during the larval stages effectively suppressed adult paraShu phenotypes, dietary lipids likely modify neural development to compensate for the defects caused by the mutations. Consistent with this notion, lipid feeding fully rescued abnormal dendrite development of class IV sensory neurons in paraShu larvae. Overall, our findings demonstrate that milk lipids are sufficient to ameliorate hyperexcitable phenotypes in Drosophila mutants, providing a foundation for future investigation of the molecular and cellular mechanisms by which dietary lipids modify genetically induced abnormalities in neural development, physiology, and behavior.


Subject(s)
Drosophila Proteins , Drosophila , Animals , Drosophila melanogaster/genetics , Drosophila Proteins/genetics , Milk , Seizures , Phenotype , Mutation/genetics , Dietary Supplements , Lipids
7.
PLoS One ; 17(10): e0276659, 2022.
Article in English | MEDLINE | ID: mdl-36288331

ABSTRACT

OBJECTIVE: Previous studies have revealed that coronary artery calcium is related to cardiovascular diseases and mortality. However, most studies have been conducted in Western countries and have excluded patients with pre-existing heart disease. We investigated the association between coronary artery calcium (CAC) and all-cause mortality in an Asian cohort and in subgroups stratified by age, sex, smoking, obesity, diabetes, cardiovascular disease, blood pressure, and biochemical parameters. METHODS: We conducted a retrospective cohort study on 4529 health examinees who underwent multidetector computed tomography in a tertiary medical center in Taiwan between 2011 and 2016. The mean follow-up was 3.5 years. Cox regression was used to estimate the relative hazards of death. Stratified analyses were performed. RESULTS: The all-cause mortality rates were 2.94, 4.88, 17.6, and 33.1 per 1000 person-years for CAC scores of 0, 1-100, 101-400, and >400, respectively. The multivariable adjusted hazard ratios (95% confidence intervals [CIs]) for all-cause mortality were 0.95 (0.53, 1.72), 1.87 (0.89, 3.90), and 3.05 (1.46, 6.39) for CAC scores of 1-100, 101-400, and >400, respectively, relative to a CAC score of 0. Compared with CAC ≤ 400, the HRs (95% CIs) for CAC > 400 were 6.46 (2.44, 17.15) and 1.94 (1.00, 3.76) in younger and older adults, respectively, indicating that age was a moderating variable (p = 0.02). CONCLUSION: High CAC scores were associated with increased all-cause mortality. Although older adult patients had higher risks of death, the relative risk of death for patients with CAC > 400 was more prominent in people younger than 65 years.


Subject(s)
Cardiovascular Diseases , Coronary Artery Disease , Vascular Calcification , Humans , Aged , Vascular Calcification/diagnostic imaging , Calcium , Coronary Artery Disease/diagnostic imaging , Retrospective Studies , Risk Factors , Risk Assessment , Cause of Death , Cohort Studies , Calcium, Dietary , Coronary Angiography
8.
Public Health Nutr ; 25(9): 2403-2414, 2022 09.
Article in English | MEDLINE | ID: mdl-35514256

ABSTRACT

OBJECTIVE: Evaluating the association of water intake and hydration status with nephrolithiasis risk at the population level. DESIGN: It is a cross-sectional study in which daily total plain water intake and total fluid intake were estimated together with blood osmolality, urine creatinine, urine osmolality, urine flow rate (UFR), free water clearance (FWC) and urine/blood osmolality ratio (Uosm:Bosm). The associations of fluid intake and hydration markers with nephrolithiasis were evaluated using multivariable logistic regression. SETTING: General US population. PARTICIPANTS: A total of 8195 adults aged 20 years or older from the National Health and Nutritional Examination Survey 2009-2012 cycles. RESULTS: The population medians (interquartile ranges, IQR) for daily total plain water intake and total fluid intake were 807 (336-1481) and 2761 (2107-3577) ml/d, respectively. The adjusted OR (95 % CI) of nephrolithiasis for each IQR increase in total plain water intake and total fluid intake were 0·92 (95 % CI 0·79, 1·06) and 0·84 (95 % CI 0·72, 0·97), respectively. The corresponding OR of nephrolithiasis for UFR, blood osmolality, Uosm:Bosm and urine creatinine were 0·87 (95 % CI 0·76, 0·99), 1·18 (95 % CI 1·06, 1·32), 1·38 (95 % CI 1·17, 1·63) and 1·27 (95 % CI 1·11, 1·45), respectively. A linear protective relationship of fluid intake, UFR and FWC with nephrolithiasis risk was observed. Similarly, positive dose-response associations of nephrolithiasis risk with markers of insufficient hydration were identified. Encouraging a daily water intake of >2500 ml/d and maintaining a urine output of 2 l/d was associated with a lower prevalence of nephrolithiasis. CONCLUSION: This study verified the beneficial role of general water intake recommendations in nephrolithiasis prevention in the general US population.


Subject(s)
Drinking , Kidney Calculi , Adult , Biomarkers/urine , Creatinine , Cross-Sectional Studies , Drinking/physiology , Humans , Kidney Calculi/epidemiology , Kidney Calculi/etiology , Kidney Calculi/prevention & control , Nutrition Surveys , Osmolar Concentration
9.
J Environ Manage ; 313: 114930, 2022 Jul 01.
Article in English | MEDLINE | ID: mdl-35367671

ABSTRACT

The recycling of lithium batteries should be prioritized, and the use of discarded alkali metal battery electrode materials as photocatalysts merits research attention. This study synthesized alkali metal cobalt oxide (MCoO2, M = Li or Na) as a photocatalyst for the photoreduction of CO2 and degradation of toxic organic substances. The optimized NaCoO2 and LiCoO2 photocatalysts increased the photocatalytic CO2-CH4 conversion rate to 21.0 and 13.4 µmol g-1 h-1 under ultraviolet light irradiation and to 16.2 and 5.3 µmol g-1 h-1 under visible light irradiation, which is 17 times higher than that achieved by TiO2 P25. The rate constants of the optimized reactions of crystal violet (CV) with LiCoO2 and NaCoO2 were 2.29 × 10-2 and 4.35 × 10-2 h-1, respectively. The quenching effect of the scavengers and electron paramagnetic resonance in CV degradation indicated that active O2•-, 1O2, and h+ play the main role, whereas •OH plays a minor role for LiCoO2. The hyperfine splitting of the DMPO-•OH and DMPO-•CH3 adducts was aN = 1.508 mT, aHß = 1.478 mT and aN = 1.558 mT, aHß = 2.267 mT, respectively, whereas the hyperfine splitting of DMPO+• was aN = 1.475 mT. The quenching effect also indicated that active O2•- and h+ play the main role and that •OH and 1O2 play a minor role for NaCoO2. The hyperfine splitting of the DMPO-•OH and DMPO+• adducts was aN = 1.517 mT, aHß = 1.489 mT and aN = 1.496 mT, respectively. Discarded alkali metal battery electrode materials can be reused as photocatalysts to address environmental pollution.


Subject(s)
Carbon Dioxide , Environmental Pollutants , Alkalies , Cobalt , Lithium , Oxides/chemistry , Photolysis
10.
Proc Natl Acad Sci U S A ; 118(30)2021 07 27.
Article in English | MEDLINE | ID: mdl-34301890

ABSTRACT

Cytosolic lipopolysaccharides (LPSs) bind directly to caspase-4/5/11 through their lipid A moiety, inducing inflammatory caspase oligomerization and activation, which is identified as the noncanonical inflammasome pathway. Galectins, ß-galactoside-binding proteins, bind to various gram-negative bacterial LPS, which display ß-galactoside-containing polysaccharide chains. Galectins are mainly present intracellularly, but their interactions with cytosolic microbial glycans have not been investigated. We report that in cell-free systems, galectin-3 augments the LPS-induced assembly of caspase-4/11 oligomers, leading to increased caspase-4/11 activation. Its carboxyl-terminal carbohydrate-recognition domain is essential for this effect, and its N-terminal domain, which contributes to the self-association property of the protein, is also critical, suggesting that this promoting effect is dependent on the functional multivalency of galectin-3. Moreover, galectin-3 enhances intracellular LPS-induced caspase-4/11 oligomerization and activation, as well as gasdermin D cleavage in human embryonic kidney (HEK) 293T cells, and it additionally promotes interleukin-1ß production and pyroptotic death in macrophages. Galectin-3 also promotes caspase-11 activation and gasdermin D cleavage in macrophages treated with outer membrane vesicles, which are known to be taken up by cells and release LPSs into the cytosol. Coimmunoprecipitation confirmed that galectin-3 associates with caspase-11 after intracellular delivery of LPSs. Immunofluorescence staining revealed colocalization of LPSs, galectin-3, and caspase-11 independent of host N-glycans. Thus, we conclude that galectin-3 amplifies caspase-4/11 oligomerization and activation through LPS glycan binding, resulting in more intense pyroptosis-a critical mechanism of host resistance against bacterial infection that may provide opportunities for new therapeutic interventions.


Subject(s)
Caspases/metabolism , Galectin 3/metabolism , Inflammasomes/immunology , Inflammation/immunology , Lipopolysaccharides/metabolism , Macrophages/immunology , Animals , Cytosol/metabolism , Galectin 3/genetics , Inflammasomes/metabolism , Inflammation/metabolism , Inflammation/pathology , Macrophages/metabolism , Macrophages/pathology , Mice , Mice, Inbred C57BL , Pyroptosis
11.
J Colloid Interface Sci ; 601: 758-772, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34098450

ABSTRACT

In recent years, lithium-containing ceramic materials have attracted considerable research attention as high-temperature adsorbents of carbon dioxide. The recycling of electrode materials from spent lithium-ion batteries for use as photocatalysts in recovering CO2 and degrading organic pollutants is worthy of exploration. Solid, magnetic ferrite-containing photocatalysts are easily separated from reaction solutions by using magnetic devices. Solid catalysts (e.g., LiFeO2, LiFe5O8, NaFeO2, and K2Fe2O4) were prepared through the calcination of Fe2O3 and M2CO3. CO2 was photoreduced and crystal violet (CV) and 2-hydroxybenzoic acid (2-HBA) were photodegraded under visible light irradiation. The optimized K2Fe2O4 photocatalyst increased the rate of photocatalytic conversion from CO2 to methane at 20.9 µmol g-1 h-1. The catalytic efficiency indicated that the optimized reaction rate constants of CV with LiFeO2, NaFeO2, and K2Fe2O4 were 2.98 × 10-1, 5.32 × 10-1, and 4.36 × 10-1 h-1, respectively. The quenching effect achieved through the use of various scavengers and the electron paramagnetic resonance in CV degradation revealed the substantial contribution of the reactive superoxide anion radical O2- and the minor roles of h+ and the OH radical. Its usefulness in the synthesis of solid-base catalyst MFeO2 is promising for environmental control and relevant applications, particularly in solar energy manufacturing.

12.
Sci Rep ; 11(1): 6499, 2021 03 22.
Article in English | MEDLINE | ID: mdl-33753796

ABSTRACT

The adrenal gland responds to heat stress by epinephrine and glucocorticoid release to alleviate the adverse effects. This study investigated the effect of acute heat stress on the protein profile and histone modification in the adrenal gland of layer-type country chickens. A total of 192 roosters were subject to acute heat stress and thereafter classified into a resistant or susceptible group according to body temperature change. The iTRAQ analysis identified 80 differentially expressed proteins, in which the resistant group had a higher level of somatostatin and hydroxy-δ-5-steroid dehydrogenase but a lower parathymosin expression in accordance with the change of serum glucocorticoid levels. Histone modification analysis identified 115 histone markers. The susceptible group had a higher level of tri-methylation of histone H3 lysine 27 (H3K27me3) and showed a positive crosstalk with K36me and K37me in the H3 tails. The differential changes of body temperature projected in physiological regulation at the hypothalamus-pituitary-adrenal axis suggest the genetic heterogeneity in basic metabolic rate and efficiency for heat dissipation to acclimate to thermal stress and maintain body temperature homeostasis. The alteration of adrenal H3K27me3 level was associated with the endocrine function of adrenal gland and may contribute to the thermotolerance of chickens.


Subject(s)
Adrenal Glands/metabolism , Chickens/metabolism , Heat-Shock Response , Histone Code , Animals , Avian Proteins/genetics , Avian Proteins/metabolism , Chickens/genetics , Hydroxysteroid Dehydrogenases/genetics , Hydroxysteroid Dehydrogenases/metabolism , Male , Thymosin/analogs & derivatives , Thymosin/genetics , Thymosin/metabolism
13.
Cell Mol Life Sci ; 78(7): 3621-3635, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33507326

ABSTRACT

Galectin 3 is a multifunctional lectin implicated in cellular proliferation, differentiation, adhesion, and apoptosis. This lectin is broadly expressed in testicular somatic cells and germ cells, and is upregulated during testicular development. Since the role of galectin 3 in testicular function remains elusive, we aimed to characterize the role of galectin 3 in testicular physiology. We found that galectin 3 transgenic mice (Lgals3-/-) exhibited significantly decreased testicular weight in adulthood compared to controls. The transgenic mice also exhibited a delay to the first wave of spermatogenesis, a decrease in the number of germ cells at postnatal day 5 (P5) and P15, and defective Sertoli cell maturation. Mechanistically, we found that Insulin-like-3 (a Leydig cell marker) and enzymes involved in steroid biosynthesis were significantly upregulated in adult Lgals3-/- testes. These observations were accompanied by increased serum testosterone levels. To determine the underlying causes of the testicular atrophy, we monitored cellular apoptosis. Indeed, adult Lgals3-/- testicular cells exhibited an elevated apoptosis rate that is likely driven by downregulated Bcl-2 and upregulated Bax and Bak expression, molecules responsible for live/death cell balance. Moreover, the percentage of testicular macrophages within CD45+ cells was decreased in Lgals3-/- mice. These data suggest that galectin 3 regulates spermatogenesis initiation and Sertoli cell maturation in part, by preventing germ cells from undergoing apoptosis and regulating testosterone biosynthesis. Going forward, understanding the role of galectin 3 in testicular physiology will add important insights into the factors governing the development of germ cells and steroidogenesis and delineate novel biomarkers of testicular function.


Subject(s)
Apoptosis , Galectin 3/physiology , Leydig Cells/pathology , Sertoli Cells/pathology , Spermatogenesis , Spermatozoa/pathology , Animals , Follicle Stimulating Hormone/metabolism , Leydig Cells/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Sertoli Cells/metabolism , Spermatozoa/metabolism , Testosterone/metabolism
14.
J Invest Dermatol ; 141(3): 503-511.e9, 2021 03.
Article in English | MEDLINE | ID: mdl-32805218

ABSTRACT

Psoriasis is a chronic inflammatory skin disease that develops under the influence of the IL-23/T helper 17 cell axis and is characterized by intense inflammation and prominent epidermal hyperplasia. In this study, we demonstrate that galectin-8, a ß-galactoside‒binding lectin, is upregulated in the epidermis of human psoriatic skin lesions as well as in a mouse model of psoriasis induced by intradermal IL-23 injections and in IL-17A‒treated keratinocytes. We show that keratinocyte proliferation is less prominent in galectin-8‒knockout mice after intradermal IL-23 treatment than in wild-type mice. In addition, we show that galectin-8 levels in keratinocytes are positively correlated with the ability of the cells to proliferate and that transitioning from mitosis into G1 phase is delayed in galectin-8‒knockout HaCaT cells after cell-cycle synchronization and release. We demonstrate by immunofluorescence staining and immunoblotting the presence of galectin-8 within the mitotic apparatus. We reveal by coimmunoprecipitation and mass spectrometry analysis that α-tubulin interacts with galectin-8 during mitosis. Finally, we show that in the absence of galectin-8, pericentrin compactness is lessened and mitotic microtubule length is shortened, as demonstrated by immunofluorescence staining. We conclude that galectin-8 is upregulated in psoriasis and contributes to the hyperproliferation of keratinocytes by maintaining centrosome integrity during mitosis through interacting with α-tubulin.


Subject(s)
Epidermis/pathology , Galectins/genetics , Interleukin-17/metabolism , Psoriasis/immunology , Animals , Cell Proliferation , Disease Models, Animal , Epidermis/immunology , Galectins/metabolism , Gene Knockout Techniques , HaCaT Cells , Humans , Interleukin-23/administration & dosage , Interleukin-23/immunology , Mice , Mice, Knockout , Mitosis/immunology , Psoriasis/pathology , Recombinant Proteins/administration & dosage , Recombinant Proteins/immunology , Tubulin/metabolism , Up-Regulation/immunology
15.
J Clin Invest ; 131(1)2021 01 04.
Article in English | MEDLINE | ID: mdl-33055419

ABSTRACT

Psoriasis is a chronic inflammatory skin disease characterized by inflammatory cell infiltration, as well as hyperproliferation of keratinocytes in skin lesions, and is considered a metabolic syndrome. We found that the expression of galectin-7 is reduced in skin lesions of patients with psoriasis. IL-17A and TNF-α, 2 cytokines intimately involved in the development of psoriatic lesions, suppressed galectin-7 expression in human primary keratinocytes (HEKn cells) and the immortalized human keratinocyte cell line HaCaT. A galectin-7 knockdown in these cells elevated the production of IL-6 and IL-8 and enhanced ERK signaling when the cells were stimulated with IL-17A. Galectin-7 attenuated IL-17A-induced production of inflammatory mediators by keratinocytes via the microRNA-146a/ERK pathway. Moreover, galectin-7-deficient mice showed enhanced epidermal hyperplasia and skin inflammation in response to intradermal IL-23 injection. We identified fluvastatin as an inducer of galectin-7 expression by connectivity map analysis, confirmed this effect in keratinocytes, and demonstrated that fluvastatin attenuated IL-6 and IL-8 production induced by IL-17A. Thus, we validate a role of galectin-7 in the pathogenesis of psoriasis, in both epidermal hyperplasia and keratinocyte-mediated inflammatory responses, and formulate a rationale for the use of statins in the treatment of psoriasis.


Subject(s)
Galectins/immunology , Interleukin-17/immunology , Keratinocytes/immunology , Psoriasis/immunology , Signal Transduction/immunology , Skin/immunology , Animals , Female , Galectins/genetics , Humans , Interleukin-17/genetics , Keratinocytes/pathology , Male , Mice , Mice, Knockout , Psoriasis/genetics , Psoriasis/pathology , Signal Transduction/genetics , Skin/pathology
16.
Medicine (Baltimore) ; 99(26): e20823, 2020 Jun 26.
Article in English | MEDLINE | ID: mdl-32590769

ABSTRACT

Gout is a chronic disease related to uric acid metabolism. It involves crystals of uric acid accumulating in the joints, causing joint pain and releasing cytokines that trigger inflammation. Inflammation is a key component in the pathogenesis of epilepsy. Thus, we conducted a cohort study to investigate if epilepsy is associated with gout and determine the risk of epilepsy in patients with gout.The gout cohort was obtained from the Registry of Catastrophic Illnesses Patient Database (RCIPD). We identified 104,238 patients who were aged 20 years or more and newly diagnosed with gout between 2000 and 2011 and 3 outpatient visits or history of gout-specific hospitalization between 2000 and 2011. Patients without gout were frequency matched with the gout cohort at a 2:1 ratio according to age, sex, comorbidities, and year of gout diagnosis.The gout cohort showed a 1.27-fold higher overall crude hazard ratio (HR) for epilepsy compared with the control cohort. After we adjusted the analyses by age, sex, and comorbidities the gout patients displayed an increased risk of epilepsy compared with the control group (adjusted HR = 1.25, 95% confidence interval = 1.15-1.36).This study revealed a significantly higher risk of epilepsy in patients with gout. It provides further evidence for the debate around the effect of gout on brain health.


Subject(s)
Epilepsy/physiopathology , Gout/physiopathology , Adult , Aged , Cohort Studies , Correlation of Data , Epilepsy/epidemiology , Female , Gout/epidemiology , Humans , Inflammation/physiopathology , Male , Middle Aged , Registries/statistics & numerical data , Risk Factors , Taiwan/epidemiology
17.
G3 (Bethesda) ; 10(4): 1327-1340, 2020 04 09.
Article in English | MEDLINE | ID: mdl-32054635

ABSTRACT

Voltage-gated sodium (Nav) channels play a central role in the generation and propagation of action potentials in excitable cells such as neurons and muscles. To determine how the phenotypes of Nav-channel mutants are affected by other genes, we performed a forward genetic screen for dominant modifiers of the seizure-prone, gain-of-function Drosophila melanogaster Nav-channel mutant, paraShu Our analyses using chromosome deficiencies, gene-specific RNA interference, and single-gene mutants revealed that a null allele of glutathione S-transferase S1 (GstS1) dominantly suppresses paraShu phenotypes. Reduced GstS1 function also suppressed phenotypes of other seizure-prone Nav-channel mutants, paraGEFS+ and parabss Notably, paraShu mutants expressed 50% less GstS1 than wild-type flies, further supporting the notion that paraShu and GstS1 interact functionally. Introduction of a loss-of-function GstS1 mutation into a paraShu background led to up- and down-regulation of various genes, with those encoding cytochrome P450 (CYP) enzymes most significantly over-represented in this group. Because GstS1 is a fly ortholog of mammalian hematopoietic prostaglandin D synthase, and in mammals CYPs are involved in the oxygenation of polyunsaturated fatty acids including prostaglandins, our results raise the intriguing possibility that bioactive lipids play a role in GstS1-mediated suppression of paraShu phenotypes.


Subject(s)
Drosophila Proteins , Glutathione Transferase , Voltage-Gated Sodium Channels , Animals , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Drosophila melanogaster/genetics , Drosophila melanogaster/metabolism , Loss of Function Mutation , Seizures , Voltage-Gated Sodium Channels/genetics
18.
Glycobiology ; 30(1): 49-57, 2019 12 12.
Article in English | MEDLINE | ID: mdl-31553041

ABSTRACT

Galectins are ß-galactoside-binding animal lectins primarily found in the cytosol, while their carbohydrate ligands are mainly distributed in the extracellular space. Cytosolic galectins are anticipated to accumulate on damaged endocytic vesicles through binding to glycans initially displayed on the cell surface and subsequently located in the lumen of the vesicles, and this can be followed by cellular responses. To facilitate elucidation of the mechanism underlying this process, we adopted a model system involving induction of endocytic vesicle damage with light that targets the endocytosed amphiphilic photosensitizer disulfonated aluminum phthalocyanine. We demonstrate that the levels of galectins around damaged endosomes are dependent on the composition of carbohydrates recognized by the proteins. By super resolution imaging, galectin-3 and galectin-8 aggregates were found to be distributed in distinct microcompartments. Importantly, galectin accumulation is significantly affected when cell surface glycans are altered. Furthermore, accumulated galectins can direct autophagy adaptor proteins toward damaged endocytic vesicles, which are also significantly affected following alteration of cell surface glycans. We conclude that cytosolic galectins control cellular responses reflect dynamic modifications of cell surface glycans.


Subject(s)
Carbohydrates/chemistry , Galectins/metabolism , A549 Cells , Animals , CHO Cells , Cell Communication , Cells, Cultured , Cricetulus , Endosomes/metabolism , Galectins/chemistry , Humans
19.
Front Oncol ; 9: 691, 2019.
Article in English | MEDLINE | ID: mdl-31428576

ABSTRACT

Background: To evaluate the efficacy of early dutasteride administration in patients with a detectable prostate-specific antigen (PSA) levels after robot-assisted radical prostatectomy (RARP). Methods: We retrospectively analyzed RARP patients whose pathological stage is T2a to T3b without lymph node or distant metastasis from 2007 to 2017. All patients received a daily dose of 0.5 mg of dutasteride when post-RARP PSA levels were increasing but had not achieved biochemical recurrence. PSA levels were monitored every 3 months after dutasteride administration. None of the patients received radiotherapy (RT) or androgen-deprivation therapy (ADT) before taking dutasteride. All follow-ups were begun from RARP to January 2019 or to the date of RT/ADT. Results: Thirty-five patients were included in this analysis. The median followed up was 53.6 months. Twenty-two patients (62.9%) showed a PSA response in which the PSA decreased more than 10% at the first follow-up after dutasteride administration. The Pathological stage > T2 (p = 0.012) and positive surgical margin (p = 0.046) were prognostic factors for a PSA response. Twenty-three out of 35 included patients (65.7%) did not require further RT/ADT. The significant risk factor was the PSA level (p = 0.011) at the beginning of dutasteride treatment. The cut-off value of the PSA level to avoid further RT/ADT was 0.195 ng/ml. Conclusions: Early dutasteride administration showed a significant decline in the PSA levels of patients with pathology stage >T2 and positive surgical margin in our retrospective hypothesis-generating study. If dutasteride was provided before the PSA value increased to 0.195 ng/ml after RARP, it would reduce the probability of acquirement of RT/ADT.

20.
Nat Commun ; 10(1): 3473, 2019 08 02.
Article in English | MEDLINE | ID: mdl-31375685

ABSTRACT

Huntington's disease (HD) is a neurodegenerative disorder that manifests with movement dysfunction. The expression of mutant Huntingtin (mHTT) disrupts the functions of brain cells. Galectin-3 (Gal3) is a lectin that has not been extensively explored in brain diseases. Herein, we showed that the plasma Gal3 levels of HD patients and mice correlated with disease severity. Moreover, brain Gal3 levels were higher in patients and mice with HD than those in controls. The up-regulation of Gal3 in HD mice occurred before motor impairment, and its level remained high in microglia throughout disease progression. The cell-autonomous up-regulated Gal3 formed puncta in damaged lysosomes and contributed to inflammation through NFκB- and NLRP3 inflammasome-dependent pathways. Knockdown of Gal3 suppressed inflammation, reduced mHTT aggregation, restored neuronal DARPP32 levels, ameliorated motor dysfunction, and increased survival in HD mice. Thus, suppression of Gal3 ameliorates microglia-mediated pathogenesis, which suggests that Gal3 is a novel druggable target for HD.


Subject(s)
Brain/pathology , Galectin 3/metabolism , Huntington Disease/pathology , Microglia/pathology , Adult , Animals , Blood Proteins , Brain/cytology , Brain/ultrastructure , Disease Models, Animal , Disease Progression , Female , Galectin 3/blood , Galectin 3/genetics , Galectins , Gene Knockdown Techniques , Humans , Huntington Disease/blood , Huntington Disease/diagnosis , Inflammasomes/metabolism , Lysosomes/metabolism , Lysosomes/ultrastructure , Male , Mice , Microglia/cytology , Microglia/ultrastructure , Microscopy, Electron, Transmission , Middle Aged , Severity of Illness Index , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...